Table 2 Summarize of enzyme kinetic parameters for five SULT activities in pooled human Liver S9.
Isoforms | Kinetic Parameters | nHLS9s-pooled | tHLS9s-pooled | rHLS9-pooled |
---|---|---|---|---|
SULT1A1a | Km (μM) | 0.88 ± 0.20 | 0.82 ± 0.06 | 2.63 ± 0.16 |
Vmax (pmol/mg/min) | 2004.77 ± 102.28 | 451.31 ± 6.88 | 3679.89 ± 67.25 | |
4-Nitrophenyl sulfate | CL (Vmax/Km, μl/mg/min) | 2285.46 | 550.15 | 1400.78 |
Kinetic mechanism | M-Mb | M-Mb | M-Mb | |
SULT1A3 | Km (μM) | 0.17 ± 0.06 | 0.83 ± 0.22 | 0.41 ± 0.09 |
Vmax (pmol/mg/min) | 35.27 ± 2.52 | 101.66 ± 10.07 | 38.67 ± 2.32 | |
Dopamine 3-o-sulfate#1 | CL (Vmax/Km, μl/mg/min) | 201.77 | 122.12 | 95.15 |
Kinetic mechanism | Substrate inhibition | Substrate inhibition | Substrate inhibition | |
Km (μM) | 0.53 ± 0.18 | 0.95 ± 0.14 | 0.76 ± 0.19 | |
Vmax (pmol/mg/min) | 6.53 ± 0.88 | 17.88 ± 0.97 | 6.66 ± 0.56 | |
Dopamine 4-o-sulfate#2 | CL (Vmax/Km, μl/mg/min) | 12.29 | 18.88 | 8.75 |
Kinetic mechanism | Substrate inhibition | Substrate inhibition | Substrate inhibition | |
SULT1B1 | Km (μM) | 2.78 ± 0.19 | 2.38 ± 0.36 | 13.18 ± 2.50 |
Vmax (pmol/mg/min) | 14.07 ± 0.22 | 6.12 ± 0.21 | 14.38 ± 1.20 | |
Aminphenol-sulfate | CL (Vmax/Km, μl/mg/min) | 5.07 | 2.57 | 1.09 |
Kinetic mechanism | M-Mb | M-Mb | M-Mb | |
SULT1E1 | Km (μM) | 10.85 ± 1.20 | 9.33 ± 0.92 | 8.11 ± 1.63 |
Vmax (pmol/mg/min) | 76.52 ± 3.56 | 30.21 ± 1.19 | 44.69 ± 5.30 | |
β-Estradiol 3-sulfate | CL (Vmax/Km, μl/mg/min) | 7.05 | 3.24 | 5.51 |
Kinetic mechanism | Biphasic | Biphasic | Biphasic | |
SULT2A1 | Km (μM) | 0.73 ± 0.15 | 0.70 ± 0.12 | 0.81 ± 0.08 |
Vmax (pmol/mg/min) | 95.14 ± 7.68 | 45.46 ± 3.44 | 81.98 ± 1.65 | |
DHEA 3-sulfate | CL (Vmax/Km, μl/mg/min) | 129.57 | 64.56 | 101.26 |
Kinetic mechanism | Substrate inhibition | Substrate inhibition | M-Mb |